Intuitive Surgical (NSDQ:ISRG) has spent more than a decade dominating the robot-assisted surgery market, and longtime CEO Gary Guthart has no plans to cede that position, he tells MassDevice.com Executive Editor Brad Perriello in this special podcast. Guthart said Sunnyvale, Calif.-based Intuitive stays focused on one criterion: “Where can we make a difference in outcomes?” Robotic surgery […]
Podcast/Feature Tease
How I built the company: Merit Medical CEO Fred Lampropoulos
Fred Lampropoulos’ life reads like something out of a Horatio Alger novel. Lampropoulos, 65, started South Jordan, Utah-based medical device company Merit Medical Systems (NSDQ:MMSI) in 1987 and has grown it to more than $500 million in annual sales. He also served in the Special Forces (Airborne), ran for public office twice in Utah and opened […]
DeviceTalks podcast: Masimo CEO Kiani talks patient safety, corporate culture and debunking the ‘innovators dilemma’
DeviceTalks flashback: Second Sight Medical’s CEO Robert Greenberg on the pursuit of the “Bionic Eye”
DeviceTalks Podcast: B. Braun Medical CEO Caroll Neubauer on the medical device tax, Obamacare and innovation
Caroll Neubauer is a man of strong opinions.
Fortunately for us, the chairman & CEO of 175-year-old German medical products conglomerate B. Braun Medical isn’t afraid to share those opinions – even though he admits that they occaisionally get him into trouble. A case in point, as you’ll hear in this podcast, is Neubauer’s passionate opposition to the medical device excise tax.
Podcast: Medtech legends and leaders on the state of medical device innovation
On July 15, 2014, MassDevice.com brought together 4 senior medtech leaders to discuss the future of the medical device industry at our DeviceTalks Boston event.
Podcast: CEO Brian Concannon on the past and future for Haemonetics at MassDevice.com’s DeviceTalks
More than a year ago, Haemonetics (NYSE:HAE) launched a major restructuring effort, moving nearly 300 manufacturing jobs out of the country in an effort to cut between $35 million and $40 million by fiscal 2018.
The cuts were painful, not only for the 42-year-old blood management company and its workers, but for CEO Brian Concannon, who grew up only a stone’s throw from the company’s headquarters in Braintree, Mass.
Podcast: Medical device execs react to Medtronic-Covidien deal, M&A activity at DeviceTalks Minnesota
Podcast: Covidien’s Enxing Seng talks Medtronic merger, future of medicine at DeviceTalks
Can Glooko disrupt the way diabetes is managed?
Glooko continues to carve out a niche in the mobile diabetes management space.
Diabetes: CeQur CEO Jim Peterson’s personal mission to improve the standard of care
Most people are brought into the medical device industry because of a passion for a specific disease or a personal connection to a condition that’s had an impact on his or her life.
For Jim Peterson, the CEO and founder of CeQur, that motivation was right inside his own house. His daughter was diagnosed with Type I diabetes at 3 years old.